Anupam Rasayan hits 52-week high on securing order worth Rs 1,100 crore

The company will be providing multiple products to the multinational firm for the next five years

Lab test, research, r&d, chemicals, medical research, vaccine, health, pharma
SI Reporter New Delhi
2 min read Last Updated : Apr 28 2021 | 3:17 PM IST
Shares of Anupam Rasayan scaled a fresh 52-week high of Rs 666, up 6 per cent, on the BSE in intra-day trade on Wednesday after the company bagged an order worth Rs 1,100 crore from a multinational life sciences company. The shares of the speciality chemicals firm which got listed on the bourses on March 24, 2021, have risen 20 per cent over its issue price of Rs 555.

At 2.20 pm, the scrip was trading 2.78 per cent higher at Rs 646.10 on the BSE as against a rise of 1.70 per cent in the S&P BSE Sensex.

"The company has received and signed Letter of Intent (LoI) amounting to Rs 1,100 crore from one of the top 10 multinational life sciences company for supplying life sciences related speciality chemicals," Anupam Rasayan said in an exchange filing. READ HERE

The company will be providing multiple products to the multinational firm for the next five years, it added.

Anupam Rasayan has over 53 domestic and international customers, including 17 multinational companies.

Commenting on the order win, Anand Desai, Managing Director at the firm said, "Securing order from a leading multinational company in the light of prevailing global uncertainty is a testament to our research and development process, latest technology, infrastructure and quality of our existing products." 

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :Anupam Rasayan India Ltd.Buzzing stocksMarketsSpeciality chemicals

Next Story